Suppr超能文献

注射后眼内炎立即玻璃体切除术和眼内抗生素的疗效。

Effectiveness of immediate vitrectomy and intravitreal antibiotics for post-injection endophthalmitis.

机构信息

Eye Clinic Sulzbach, Knappschaft Hospital Saar, An der Klinik 10, 66280, Sulzbach, Germany.

Centre for Ophthalmology, University Eye Hospital Tuebingen, Schleichstraße 12, 72076, Tuebingen, Germany.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2021 Jun;259(6):1609-1615. doi: 10.1007/s00417-021-05071-w. Epub 2021 Jan 27.

Abstract

PURPOSE

To show that an immediate vitrectomy with an intravitreal injection of antibiotics can be an effective approach for the treatment of acute endophthalmitis following intravitreal injections.

METHODS

We reviewed all cases of clinical endophthalmitis caused by an intravitreal injection that were treated in our department between March 2012 and November 2019. Only patients that underwent a vitrectomy within 6 h after presentation to the clinic and with a documented visual acuity shortly before the causative event were included. Baseline best-corrected visual acuity (BCVA) before the causative event was compared to BCVA measured within a follow-up period of 8 months (up to 14 months).

RESULTS

In total, 30 eyes of 30 patients were included. The BCVA before the intraocular infection was a mean value of 0.55 logMAR, and the BCVA on the day of the endophthalmitis decreased significantly to 1.66 logMAR. Within 2 months following the pars plana vitrectomy (PPV), the mean BCVA improved to 0.83 logMAR. Eight months following PPV (mean value, 8.20 months; SD, 3.59 months), the mean BCVA was 0.63 logMAR. In the last follow-up interval most of the eyes recovered, and the BCVA did not differ significantly from baseline. Two eyes underwent further pars plana surgery during the follow-up period. No enucleation was required.

CONCLUSION

In this study, we have shown that an immediate vitrectomy with subsequent intravitreal injection of antibiotics is an effective option for treating post-injection endophthalmitis and frequently results in recovery of vision; thus, it should be performed as early as possible, where available.

摘要

目的

表明玻璃体切割术联合玻璃体内注射抗生素可以作为治疗眼内注射后急性眼内炎的有效方法。

方法

我们回顾了 2012 年 3 月至 2019 年 11 月期间在我科治疗的所有因眼内注射引起的临床眼内炎病例。仅纳入在就诊后 6 小时内行玻璃体切割术且在致病因发生前有明确视力记录的患者。将致病因发生前的最佳矫正视力(BCVA)与随访期内(最长 14 个月)的 BCVA 进行比较。

结果

共纳入 30 例 30 眼。眼内感染前 BCVA 的平均值为 0.55 logMAR,眼内炎当天的 BCVA 显著下降至 1.66 logMAR。玻璃体切割术后 2 个月内,平均 BCVA 提高至 0.83 logMAR。玻璃体切割术后 8 个月(平均 8.20 个月,标准差 3.59 个月),平均 BCVA 为 0.63 logMAR。在最后一次随访间隔中,大多数眼视力恢复,BCVA 与基线无显著差异。在随访期间,有 2 只眼需要进一步行玻璃体切割术。无眼球摘除。

结论

本研究表明,玻璃体切割术联合随后的玻璃体内注射抗生素是治疗注射后眼内炎的有效方法,且常可恢复视力;因此,只要条件允许,应尽早进行这种治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验